Design and rationale of the North Indian ST-Segment Elevation Myocardial Infarction Registry: A prospective cohort study.
STEMI
cardiovascular outcomes
myocardial infarction
registry
Journal
Clinical cardiology
ISSN: 1932-8737
Titre abrégé: Clin Cardiol
Pays: United States
ID NLM: 7903272
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
06
06
2019
revised:
16
09
2019
accepted:
18
09
2019
pubmed:
9
10
2019
medline:
21
5
2020
entrez:
9
10
2019
Statut:
ppublish
Résumé
ST-segment elevation myocardial infarction (STEMI) is associated with increased mortality and morbidity. Although remarkable progress has been made in the management of STEMI in high-income countries, contemporary data to evaluate processes and outcomes of STEMI care in India is limited. The North Indian ST-segment elevation myocardial infarction (NORIN STEMI) registry is a prospective cohort study based at government funded and largely free of cost tertiary medical centers in New Delhi, India. These hospitals serve a large proportion of the patients with lower socioeconomic status presenting from multiple states in India, as many centers in these states lack adequate specialized cardiovascular care. The study has been approved by the Institutional Review Boards of each institution and informed consent has been obtained from study participants. The NORIN STEMI registry aims to provide important insights regarding contemporary risk factors profiles, practice patterns, and prognosis in patients with STEMI in an underserved population in North India. These findings may identify opportunities to improve the outcomes of patients with STEMI in India.
Identifiants
pubmed: 31593344
doi: 10.1002/clc.23278
pmc: PMC6906983
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1140-1146Informations de copyright
© 2019 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc.
Références
Indian Heart J. 2005 May-Jun;57(3):217-25
pubmed: 16196178
Lancet. 2008 Apr 26;371(9622):1435-42
pubmed: 18440425
Circulation. 2016 Jul 26;134(4):304-13
pubmed: 27440003
Circulation. 2018 Nov 13;138(20):e618-e651
pubmed: 30571511
Circulation. 2019 Feb 19;139(8):1047-1056
pubmed: 30586725
Lancet Glob Health. 2018 Dec;6(12):e1339-e1351
pubmed: 30219317
Indian Heart J. 2017 Apr;69 Suppl 1:S63-S97
pubmed: 28400042
Clin Cardiol. 2019 Dec;42(12):1140-1146
pubmed: 31593344
Lancet. 2017 Dec 2;390(10111):2437-2460
pubmed: 29150201
J Am Coll Cardiol. 2018 Jun 5;71(22):2540-2551
pubmed: 29535062
J Hypertens. 2018 Oct;36(10):1953-2041
pubmed: 30234752
Am J Med. 2018 Mar;131(3):284-292.e1
pubmed: 29106977
Clin Cardiol. 2017 Nov;40(11):955-961
pubmed: 28805969
JAMA. 2004 Jun 9;291(22):2727-33
pubmed: 15187054
Circulation. 2018 Dec 11;138(24):2855-2857
pubmed: 30565984
N Engl J Med. 2015 Apr 2;372(14):1333-41
pubmed: 25830423
J Am Coll Cardiol. 2018 Jul 3;72(1):79-95
pubmed: 29957235
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Circulation. 2000 Oct 24;102(17):2031-7
pubmed: 11044416
Indian Heart J. 2016 Mar-Apr;68(2):118-27
pubmed: 27133317
Atherosclerosis. 2018 May;272:80-86
pubmed: 29579671
Int J Cardiol. 2017 Dec 1;248:1-6
pubmed: 28942868
Indian Heart J. 2015 Sep-Oct;67(5):497-502
pubmed: 26432748
J Am Coll Cardiol. 2018 Jan 23;71(3):292-302
pubmed: 29141201
Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):436-43
pubmed: 23800985
J Am Coll Cardiol. 2019 May 21;73(19):2439-2450
pubmed: 31097165
Lancet. 2015 Dec 12;386(10011):2422-35
pubmed: 26700532
JAMA Cardiol. 2017 May 1;2(5):498-505
pubmed: 28273293
Eur Heart J. 2013 Jan;34(2):121-9
pubmed: 22961945
Circulation. 2013 Jan 29;127(4):529-55
pubmed: 23247303